Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months

Neurology

Volumn 73, Issue 12, 2009, Pages 949-953

  Llufriu, S ^b   Castillo, J ^d   Blanco, Y ^b   Ramio Torrenta L ^b   Rio J ^d   Valles M ^f   Lozano, M ^c   Castella M D ^e   Calabia, J ^f   Horga, A ^d   Graus, F ^b   Montalban, X ^d   Saiz, Albert ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b Department of Neurology ^*  (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CEM Cat   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MITOXANTRONE;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DEMYELINATING DISEASE; ENCEPHALOMYELITIS; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN THROMBOSIS; VIRUS HEMORRHAGIC FEVER; VISUAL ACUITY;

EID: 70349682600     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b879be     Document Type: Article

References (17)

1. The Canadian Cooperative Multiple Sclerosis Study Group. The Canadian cooperative trials of cyclophospha-mide and plasma exchange in progressive multiple sclerosis. Lancet 1991;337:441-446.
2. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1989;39:1143-1149.
3. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999;46:878-886.
4. Bennetto L, Totham A, Healy P, Massey E, Scolding N. Plasma exchange in episodes of severe inflammatory demy-elination of the central nervous system: a report of six cases J Neurol 2004;251:1515-1521.
5. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007;13:128-132. (Pubitemid 46152772)
6. Yücesan C, Arslan O, Arat M, et al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfus Apher Sci 2007;36:103-107.
7. Lin CH, Jeng JS, Yip PK. Plasmapheresis in acute disseminated encephalomyelitis. J Clinical Apheresis 2004;19: 154-159.
8. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Mala-chowski ME, Chuerchill WH. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995;45:824-827.
9. Meca-Lallana JE, Rodriguez-Hilario H, Martínez-Vidal S, et al. Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system-an observation study. Rev Neurol 2003;37:917-926.
10. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-146.
11. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
12. Wingerchuk DM, Lenon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromy-elitis optica. Neurology 2006;66:1485-1489.
13. Mendez MF, Pogacar S. Malignant monophasic multiple sclerosis or "Marburg's disease." Neurology 1998;38:1153-1155.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
15. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R. Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 2004;63:1081-1083.
16. Lehmann HC, Hartung HP, Hetzel GR, Stüve O, Kieseier BC. Plasma exchange in neuroimmunological disorders. Arch Neurol 2006;63:930-935.
17. Keegan M, König F, McClelland R, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005;366:579-582.